Bedrift	Dele, %
Compass Therapeutics, Inc.	10.58
Mereo BioPharma Group plc	9.22
Spruce Biosciences, Inc.	6.34
Inozyme Pharma, Inc.	5.96
Immunocore Holdings plc	5.34
Blueprint Medicines Corporation	4.71
Accolade, Inc.	4.5
Aclaris Therapeutics, Inc.	4.23
Xilio Therapeutics, Inc.	4.18
Vincerx Pharma, Inc.	4.16
Phreesia, Inc.	3.91
Acumen Pharmaceuticals, Inc.	3.83
Agios Pharmaceuticals, Inc.	3.83
EDAP TMS S.A.	3.74
Evolent Health	3.43
Immatics N.V.	3.28
IMARA Inc.	3.2
Sagimet Biosciences Inc. Series A Common Stock	2.43
Leap Therapeutics, Inc.	2.38
Mineralys Therapeutics, Inc.	2.35
Warby Parker Inc.	2.1
AcelRx Pharmaceuticals, Inc.	1.94
ESSA Pharma Inc.	1.53
Cerevel Therapeutics Holdings, Inc.	1.47
Compugen Ltd	1.45
Olink Holding AB (publ)	1.35
LifeStance Health Group, Inc.	1.25